Captor Therapeutics

Poland
Nowosielce-Gniewosz, Subcarpathia, Poland, 54-427

Company profile

Captor Therapeutics company profile

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome".

Business identity

Contact email
[email protected]
Phone number
+48 537 869 089
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
54-427
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Last funding
Grant / 2025-02-17
Investors
1
Lead investors
1
Founders
1
Articles
17
Exited on
2021-04-19

Founders and investors

Founders

Sylvain Cottens

Lead investors

EIC Accelerator

Investors

EIC Accelerator